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Troponin T (TnT) is the sarcomeric thin filament anchoring subunit of the troponin complex
in striated muscles. A nonsense mutation in exon 11 of the slow skeletal muscle isoform
of TnT (ssTnT) gene (TNNT1) was found in the Amish populations in Pennsylvania and
Ohio. This single nucleotide substitution causes a truncation of the ssTnT protein at
Glu180 and the loss of the C-terminal tropomyosin (Tm)-binding site 2. As a consequence,
it abolishes the myofilament integration of ssTnT and the loss of function causes an
autosomal recessive nemaline myopathy (NM). More TNNT1 mutations have recently
been reported in non-Amish ethnic groups with similar recessive NM phenotypes. A
nonsense mutation in exon 9 truncates ssTnT at Ser108, deleting Tm-binding site 2
and a part of the middle region Tm-binding site 1. Two splicing site mutations result
in truncation of ssTnT at Leu203 or deletion of the exon 14-encoded C-terminal end
segment. Another splicing mutation causes an internal deletion of the 39 amino acids
encoded by exon 8, partially damaging Tm-binding site 1. The three splicing mutations
of TNNT1 all preserve the high affinity Tm-binding site 2 but still present recessive
NM phenotypes. The molecular mechanisms for these mutations to cause myopathy
provide interesting models to study and understand the structure-function relationship of
TnT. This focused review summarizes the current knowledge of TnT isoform regulation,
structure-function relationship of TnT and how various ssTnT mutations cause recessive
NM, in order to promote in depth studies for further understanding the pathogenesis and
pathophysiology of TNNT1 myopathies toward the development of effective treatments.
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TROPONIN IN VERTEBRATE STRIATED MUSCLES AND FIBER
TYPE-SPECIFIC ISOFORMS
Vertebrates have two types of striated muscles, i.e., skeletal muscle and cardiac muscle. The
basic contractile apparatus of vertebrate striated muscle is the sarcomeres that are in tandem
repeats in the myofibrils. The sarcomeres consist of overlapping myosin thick filaments and actin
thin myofilaments (Tobacman, 1996; Gordon et al., 2000). Muscle contraction is powered by
actin-activated myosin ATPase (Cooke, 1986), which is regulated by intracellular Ca2+ through the
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troponin complex associated with the thin filament (Gordon
et al., 2000). The binding of Ca2+ to troponin induces a series of
allosteric changes in the thin filament, allowing the myosin head
to form a strong cross-bridge with F-actin to activate myosin
ATPase and initiate contraction (Leavis and Gergely, 1984).
Vertebrate skeletal muscle contains slow twitch and fast
twitch types of fibers (Eddinger et al., 1985; Sosnicki et al.,
1989). Correspondingly, muscle myosin and troponin have both
evolved into slow and fast fiber type-specific isoforms. Slow and
fast skeletal muscle fibers express type I and type II myosin,
respectively, and these myosin isoenzymes differ in their ATPase
activity (Bárány, 1967). Previous studies in multiple laboratories
have demonstrated the contribution of four skeletal muscle
myosin heavy chain (MHC) isoforms (type I, IIa, IIb, and IIx)
to the magnitude and velocity of contraction of different types of
muscle fibers (Ruff and Whittlesey, 1991; Johnson et al., 1994).
The troponin complex is at the center of the Ca2+-regulation
of muscle contraction (Leavis and Gergely, 1984). Troponin
consists of three protein subunits: The Ca2+-binding subunit
TnC, the inhibitory subunit TnI, and the tropomyosin-binding
subunit TnT (Greaser and Gergely, 1973). To convert the cellular
signal of rising cytosolic Ca2+ originated from sarcolemmal
electrical activity to myofilament movements, troponin functions
through cooperative interactions among the three subunits and
with tropomyosin and the actin thin filament (Tobacman, 1996;
Gordon et al., 2000).
Among the three subunits of troponin, TnC belongs to a
family of Ca2+ signaling proteins including calmodulin and
myosin light chains (Collins, 1991). A fast isoform of TnC is
found in fast twitch skeletal muscle fibers (Gahlmann and Kedes,
1990), whereas slow twitch skeletal muscle and cardiac muscle
share another isoform of TnC (Parmacek and Leiden, 1989). In
contrast, TnI and TnT are striated muscle-specific proteins, and
each has diverged into three homologous isoforms corresponding
to the cardiac, slow skeletal and fast skeletal types of muscle fibers
(Hastings, 1997; Perry, 1998).
The three TnI and three TnT isoform genes are closely linked
in three pairs in the chromosomal genome of vertebrates. The fast
TnI and fast TnT genes are linked in one pair (Barton et al., 1997),
which is consistent with their linked functions in adult skeletal
muscles. However, the cardiac TnI gene is linked to the slow TnT
gene (Huang and Jin, 1999) and the slow TnI gene is linked to
the cardiac TnT gene (Tiso et al., 1997), which are different from
their linked fiber type-specific expressions in adult slow skeletal
muscle or heart. While such scrambled linkages of the two pairs
of TnI and TnT genes indicate that the TnT and TnI isoform
gene expression is regulated by the cellular environment rather
than by genomic organization, slow TnI and cardiac TnT express
and function together in embryonic heart (Jin, 1996). Embryonic
cardiac muscle expresses solely slow skeletal muscle TnI that
is replaced by cardiac TnI during late embryonic and early
postnatal development (Saggin et al., 1989; Jin, 1996). Therefore,
they are originally a functional pair of linked genes, whereas the
cardiac TnI and slow TnT genes emerged later as the newest pair
(Chong and Jin, 2009).
Mutations in the three TnT isoform genes TNNT1, TNNT2,
and TNNT3 encoding slow skeletal muscle TnT, cardiac TnT,
and fast skeletal muscle TnT, respectively, have been reported
to cause cardiac and skeletal myopathies. During the last two
decades, numerousmutations inTNNT2 gene have been found to
cause various types of cardiomyopathies (Knollmann and Potter,
2001; Sheng and Jin, 2014). In contrast, rather few mutations
in skeletal muscle TnT isoform genes have been reported in
skeletal muscle diseases (Wei and Jin, 2016), among which five
mutations in theTNNT1 gene encoding slow TnT cause nemaline
myopathies (NM). A nonsense mutation in TNNT1 was first
identified in the Old Order Amish (Johnston et al., 2000). The
identification and mechanistic studies of the Amish NM (ANM)
(Jin et al., 2003; Wang et al., 2005) have raised clinical awareness
and the inclusion of testing forTNNT1mutations in the diagnosis
of myopathies. As a result, four more truncation or internal
deletion mutations in TNNT1 gene have recently been reported
in multiple other ethnic groups around the world to cause
myopathies similar to that of ANM (van der Pol et al., 2014;
Marra et al., 2015; Abdulhaq et al., 2016). No effective treatment
is currently available for TNNT1 NM.
Nemaline myopathies are neuromuscular disorders
characterized by muscle weakness and rod-shaped or “nemaline”
inclusions in skeletal muscle fibers (Wallgren-Pettersson et al.,
2011; Nance et al., 2012). The different TNNT1 NM mutations
all have recessively inherited lethal phenotypes, indicating
that the various truncations or internal deletion of slow TnT
all result in the loss of function. This notion and the critical
importance of slow skeletal muscle fibers have been confirmed
for the case of ANM mutation (Jin et al., 2003; Wang et al.,
2005). To understand the molecular basis for the pathogenesis
and pathophysiology of TNNT1 NM will provide insights into
the structure-function relationship of TnT and the mechanism
of muscle contraction. The present review is thus focusing on
the myopathy mutations of slow skeletal muscle isoform of
TnT. It is our hope that the in depth discussions will help to
stimulate further research leading to the development of targeted
treatment of these lethal skeletal muscle diseases.
STRUCTURE-FUNCTION RELATIONSHIP
OF TROPONIN T
TnT is a 30–35-kDa protein (Greaser and Gergely, 1973). Based
on available sequence information, the length of vertebrate TnT
polypeptide chain ranges from 223 to 305 amino acids. This large
size variation of TnT isoforms across species is almost entirely
due to the variable length of the N-terminal variable region, from
nearly absent in some fish fast skeletal muscle TnT to more than
70 amino acids long in avian and mammalian cardiac TnT (Jin
et al., 2008; Wei and Jin, 2011; Jin, 2016). Primary structural
data showed that while the N-terminal region is hypervariable
in length and amino acid sequences, the amino acid sequences of
the middle and C-terminal regions of TnT are highly conserved
among the three muscle-type isoforms and across vertebrate
species (Jin et al., 2008; Jin, 2016; Wei and Jin, 2016).
Electron microscopic studies showed that the TnT molecule
has an extended conformation (Cabral-Lilly et al., 1997; Wendt
et al., 1997). High-resolution X-ray crystallographic structures
Frontiers in Physiology | www.frontiersin.org 2 October 2016 | Volume 7 | Article 449
Mondal and Jin TNNT1 Myopathies
have been obtained for the core region of human cardiac
troponin complex (Takeda et al., 2003) and chicken fast skeletal
muscle troponin complex (Vinogradova et al., 2005). These
solved high-resolution structures of the troponin complex
contained entire TnC and most regions of TnI, but only a small
C-terminal portion of TnT. The data showed that TnT interfaces
with TnI in a coiled-coil structure (i.e., the I-T arm) formed by
the segments of L224-V274 of cardiac TnT and F90-R136 of cardiac
TnI in human cardiac troponin or E199-Q245 of fast TnT and
G55-L102 of fast TnI in chicken fast skeletal muscle troponin.
The C-terminal portion of the I-T arm also interacts with TnC.
The observation that the N-terminal and the middle region as
well as the very C-terminal end of TnT were not resolved in the
high resolution crystallographic structures implicates a flexibility
of these regions, likely reflecting their allosteric functions in the
troponin regulation of muscle contraction.
Complementary to the crystallographic structure, the
functional sites and the structure-function relationship of TnT
have been extensively investigated in protein binding studies
using TnT fragments generated from limited chymotryptic
and CNBr digestions. The structural and functional domains
of TnT are summarized in Figure 1. The classic chymotryptic
fragments T1 and T2 of rabbit fast skeletal TnT (Tanokura et al.,
1981) were studied for their bindings with other regulatory
proteins in muscle thin filament. The ∼100 amino acids C-
terminal chymotryptic fragment T2 interacts with TnI and
TnC and binds to the middle region of tropomyosin (Heeley
et al., 1987; Schachat et al., 1995). The chymotryptic fragment
T1 that contains both the N-terminal variable region and the
middle conserved region of TnT binds the head-tail junction
of tropomyosins in the actin thin filament (Heeley et al., 1987;
Schachat et al., 1995). The tropomyosin-binding activity of the
T1 fragment resides in the 81 amino acids CNBr fragment CB2
of rabbit fast skeletal muscle TnT, which represents a largely
α-helical structure (Pearlstone et al., 1976, 1977) in the middle
conserved region of TnT. The CNBr fragment CB3 of rabbit
fast skeletal muscle TnT (amino acids 2-50) representing the N-
terminal variable region does not bind TnI, TnC, or tropomyosin
(Pearlstone and Smillie, 1982; Ohtsuki et al., 1984; Heeley et al.,
1987; Perry, 1998).
More recent studies using genetically engineered TnT
fragments and mapping with site-specific monoclonal antibody
probes showed that the T1 region tropomyosin-binding site 1 of
TnT included a 39-amino acid segment at the N-terminal portion
of the middle conserved region of TnT (Jin and Chong, 2010).
Its downstream boundary was further extended to beyond S108,
the site of a TNNT1 NM nonsense mutation that causes partial
destruction of the tropomyosin binding site 1 (Amarasinghe
et al., 2016). The tropomyosin binding site 2 in the T2 fragment
was mapped to a 25-amino acid segment at the beginning of the
T2 fragment (Jin and Chong, 2010). Amino acid sequences of
these segments containing the two tropomyosin binding sites are
highly conserved in the three muscle-type specific TnT isoforms
and across vertebrate species (Jin et al., 2008).
Although, the N-terminal region of TnT does not bind
any known myofilament proteins, its structure is regulated by
alternative splicing during late embryonic and early postnatal
development of the heart (Jin and Lin, 1988) and skeletal muscles
(Wang and Jin, 1997), and in pathologic adaptation (Larsson
et al., 2008). These developmental and adaptive regulations
of the N-terminal variable region of TnT suggested functional
significances. The entire N-terminal variable region of cardiac
TnT can also be selectively removed during cardiac adaptation to
acute energetic crisis by restrictive proteolysis (Zhang et al., 2006;
Feng et al., 2008). Similar modification can also be produced in
fast skeletal muscle TnT (Zhang et al., 2006).
In vitro studies have demonstrated the role of the N-terminal
region in altering the molecular conformation of TnT in the
middle and C-terminal regions and the interactions with TnI,
TnC, and tropomyosin (Wang and Jin, 1998; Jin and Root,
2000; Jin et al., 2000; Biesiadecki et al., 2007). The physiological
and pathological significances of the regulatory effects of the N-
terminal variable region of TnT have also been demonstrated in
ex vivoworking heart and cardiomyocyte studies using transgenic
mice expressing N-terminal modified TnT in the heart (Pan et al.,
1991; Chandra et al., 1999; Biesiadecki et al., 2002; Feng et al.,
2008; Wei et al., 2010; Wei and Jin, 2015).
Protein binding studies further demonstrated that the N-
terminal variable region of TnT remotely modulates the binding
affinity of TnT for tropomyosin by reducing the affinities
of both site 1 in the middle region (Amarasinghe and Jin,
2015) and site 2 in the C-terminal region (Amarasinghe
et al., 2016). This inhibitory regulation has been most clearly
demonstrated in the case of the TNNT1 exon 8 deletion
NM mutant, where removal of the N-terminal segment very
effectively restored tropomyosin binding affinity diminished by
the mutation (Amarasinghe et al., 2016). These data further
suggest that the conserved structures in the middle and C-
terminal regions of TnT confer a baseline state of troponin
function that is similar for cardiac, slow and fast skeletal muscle
isoforms. The diverged N-terminal structure of the muscle
type-specific TnT isoforms provides a regulatory mechanism to
fine tune the function of troponin adapted to the contractility
requirement in different muscle types and in physiological and
pathophysiological adaptations.
The 9 amino acids at the very C-terminal end of TnT are highly
conserved among the three muscle type isoforms and across
vertebrate species (Jin et al., 2008). The functional significance
of this segment has been an interest of experimental research.
There is no direct evidence for binding of this C-terminal
segment of TnT with any other myofilament proteins. This
segment was not resolved in the high-resolution crystal structure
of either cardiac or fast skeletal muscle troponin complex
(Takeda et al., 2003; Vinogradova et al., 2005), implicating
its possible nature as a flexible and allosteric structure. The
recent finding of a splicing site mutation in TNNT1 gene,
which deletes the exon 14-encoded segment of the C-terminal
14 amino acids and causes NM (van der Pol et al., 2014),
supports a critical role of the conserved C-terminal segment
of TnT.
Consistently with this notion, mutations of single amino
acid substitutions (R278C or R286C) in the C-terminal end
segment, partial deletion (W287ter) or error-splice out of exon
17 encoding this segment in cardiac TnT have been found
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FIGURE 1 | Structural and functional domains of TnT and TNNT1 NM mutations. Illustrated on a structure-function model of the troponin complex (the
crystallographic structure was adapted from Takeda et al., 2003), the positions of slow TnT Ser108, Glu180, Leu203 and exon 14 truncations and exon 8 deletion are
indicated together with the interaction sites for tropomyosin (Tm), TnI and TnC. The long arrows propose the effects of N-terminal variable region on the overall
conformation and function of TnT. In this model, the effect of N-terminal segment on decreasing Tm-binding affinity was augmented by the internal deletion of the
exon 8-encoded segment.
to cause cardiomyopathy (Thierfelder et al., 1994; Watkins
et al., 1995; Richard et al., 2003). Biochemical and biophysical
studies have demonstrated that the R278C mutant of cardiac
TnT produces a slightly increased Ca2+ sensitivity with a
significant elevation of sub-half-maximal force (Morimoto
et al., 1999). Deletion of the C-terminal 14 amino acids of
cardiac TnT resulted in lower level activation of myofilament
ATPase with reduced effectiveness of Ca2+-troponin to switch
the thin filament from the off to the on state (Mukherjea
et al., 1999) and also caused detectable ATPase activation in
the absence of Ca2+ showing hindered ability of regulated
actin filament in conferring the inactive state (Franklin et al.,
2012).
GENES ENCODING TROPONIN T
ISOFORMS
Three homologous genes have evolved in vertebrate species
encoding the cardiac (TNNT2), slow skeletal muscle (TNNT1)
and fast skeletal muscle (TNNT3) isoforms of TnT (Cooper and
Ordahl, 1985; Breitbart and Nadal-Ginard, 1986; Jin et al., 1992;
Farza et al., 1998; Huang et al., 1999; Hirao et al., 2004). It has
been shown in avian and mammalian species that TNNT1 and
TNNT3 genes specifically express in the slow and fast twitch
skeletal muscle fibers, respectively. In contrast, TNNT2 gene
expresses in embryonic and adult cardiac muscle as well as
transiently expresses in embryonic and neonatal skeletal muscles,
including both slow and fast fiber dominant muscles (Toyota and
Shimada, 1983; Cooper and Ordahl, 1985; Jin, 1996).
The functional diversity of TnT isoforms has physiological
significances. An interesting example is that the cardiac muscle
of toad (Bufo) expresses exclusively slow skeletal muscle TnT
together with cardiac forms of TnI and myosin (Feng et al.,
2012). This is a unique case since all vertebrate species studied
to date from fish to human including the closely related
genus frog (Rana) express only cardiac TnT in the cardiac
muscle. Analysis of cardiac function demonstrated that toad
hearts generated lower maximum stroke volume but significantly
higher resistance to the increase of afterload than that of frog
hearts (Feng et al., 2012). This feature is consistent with the
unique functional requirement for the toad heart to work under
drastically fluctuation of blood volumes and regulation via
vasoconstrictions. This finding demonstrates a fitness selection
value of the evolutionary adaptation of utilizing slow skeletal
muscle TnT in toad cardiac muscle. The specific structure(s) of
slow TnT in altering the contractility of toad cardiac muscle is
worth investigating in order to better understand the critical
role of slow TnT in skeletal muscle function as well as the
development of a way targeting cardiac TnT to treat heart failure.
The evolutionary linage of the three TnT isoform genes
have been thoroughly investigated by sequence analysis
and protein epitope studies (Chong and Jin, 2009). Using
monoclonal antibodies as site-specific epitope probes, a method
was developed to detect evolutionarily suppressed molecular
conformation by removing the suppressor structures, such as
the evolutionarily added N-terminal variable region. The results
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demonstrated three-dimensional structure evidence for the
evolutionary relationships between TnI and TnT and among
their muscle type-specific isoforms (Chong and Jin, 2009). The
data further demonstrate a novel mode of protein evolution by
allosterically suppressing the ancestral molecular conformation
with the evolutionary addition of a modulatory structure, in
which the present-day form of TnT isoforms with diverged
primary and folded structures have the potential of restoring
ancestral conformations after removing the evolutionarily added
repressor structure (Chong and Jin, 2009).
The adult heart and skeletal muscles express the three TnT
isoform in a muscle fiber type-specific manner (Jin, 2016).
Knockout of the TNNT2 gene encoding cardiac TnT resulted
in embryonic lethality (Nishii et al., 2008). Consistent with the
differentiated role of slow muscle fibers critical to the mobility of
animals (Rome et al., 1988), the loss of ssTnT results in severe
NMs (Johnston et al., 2000; Jin et al., 2003; van der Pol et al.,
2014; Marra et al., 2015; Abdulhaq et al., 2016). Therefore, the
three muscle type TnT isoforms play non-redundantly roles in
the functions of the three types of striated muscle.
In addition to the sequence and protein conformation lineage
data, the undifferentiated utilization of the same TnC isoform in
cardiac and slow skeletal muscles also supports the hypothesis
that the emergence of the cardiac and slow TnI-TnT gene pairs
was a relatively recent event of evolutionary divergence (Chong
and Jin, 2009). A further support to this notion that among the
three TnI-TnT gene pairs, cardiac TnI-slow TnT genes form the
newest pair is the presence of a unique N-terminal extension in
cardiac TnI, an additional structure that is absent in fast and slow
skeletal muscle TnI isoforms (Parmacek and Solaro, 2004). The
latest emergence of the slow TnT gene may be a landmark of
vertebrate evolution and its functional significance requires more
investigation.
ALTERNATIVE SPLICING
Expression of the three TnT isoform genes is regulated at the
transcriptional level as well as via alternative RNA splicing (Jin
et al., 2008; Wei and Jin, 2011, 2016). The splicing variants
add to the diversity of TnT structure for fine tuning of
muscle contractility during development and in adaptation to
physiological stress and pathological conditions.
Cardiac TnT
The mammalian cardiac TnT gene (TNNT2) contains 14
constitutively expressed exons and three alternatively spliced
exons (Jin et al., 1992, 1996; Farza et al., 1998). Exon 5 of
cardiac TnT gene, which encodes 9 or 10 amino acids in the
N-terminal variable region, is included in embryonic but not
adult cardiac TnT (Jin and Lin, 1989). Exon 4 of cardiac TnT
gene is alternatively spliced independent of developmental state
(Jin et al., 1996). The avian cardiac TnT gene contains 16
constitutively spliced exons and only one alternative exon (the
embryonic exon 5) (Cooper andOrdahl, 1985). Correspondingly,
four mammalian and two avian cardiac TnT N-terminal
alternative splicing variants have been found in normal cardiac
muscle.
The inclusion or exclusion of exon 5 generates an embryonic
to adult cTnT isoform switching during development (Cooper
and Ordahl, 1985; Jin and Lin, 1988; Jin et al., 1996). When
TNNT2 gene is transiently expressed in embryonic and neonatal
skeletal muscles, the alternative splicing pattern is synchronized
to that in the heart (Jin, 1996). The timing of the switching of
TNNT2 alternative splicing varies in different species, indicating
regulation by a systemic clock, rather than adaptation to changes
in contractile function (Jin, 1996).
Splice out of exon 4 that encodes 4-5 amino acids in the
N-terminal variable region of cardiac TnT increases in failing
human hearts (Anderson et al., 1995; Mesnard-Rouiller et al.,
1997), diabetic (Akella et al., 1995) and hypertrophic (McConnell
et al., 1998) rat hearts. Aberrant splice out of N-terminal coding
exons of cardiac TnT (exon 7 in dogs equivalent to exon 8 in
turkey) is found in dilated cardiomyopathy (Biesiadecki et al.,
2002; Biesiadecki and Jin, 2002).
There is another alternatively spliced exon (exon 13) encoding
a short segment of 2 or 3 amino acids between the T1 and T2
regions of mammalian cardiac TnT (Jin et al., 1992, 1996). The
functional significance of this variable region is unknown.
Fast Skeletal Muscle TnT
Mammalian fast skeletal muscle TnT gene contains 19 exons, of
which exons 4, 5, 6, 7, 8, and a fetal exon encoding segments in
the N-terminal variable region are alternatively spliced (Breitbart
and Nadal-Ginard, 1986; Briggs and Schachat, 1993; Wang and
Jin, 1997). Additional alternative N-terminal coding exons are
present in avian TNNT3 gene (Smillie et al., 1988; Ogut and Jin,
1998; Miyazaki et al., 1999; Jin and Samanez, 2001). Seven P
exons are located between exon 5 and 6 in the N-terminal variable
region of avian fsTnT encode a unique Tx segment (Smillie
et al., 1988; Jin and Smillie, 1994; Miyazaki et al., 1999; Jin and
Samanez, 2001). A w exon and a y exon are found between exons
4-5 and 7-8, respectively (Schachat et al., 1995).
The alternative splicing of two mutually exclusive C-terminal
exons (16 and 17) each encoding a segment of 14 amino acids
also occurs in TNNT3 expression (Wang and Jin, 1997). This
alternatively spliced segment of fast TnT is in the interface
with TnI and TnC (Wei and Jin, 2016). Incorporation of exon
17-encoded segment weakened binding of TnT to TnC and
tropomyosin (Wu et al., 1995). This region also shows diversity
between mammalian and avian cardiac TnT, where the avian
cardiac TnT gene contains an additional exon encoding two
amino acids (Cooper and Ordahl, 1985).
Like that of cardiac TnT, expression of TNNT3 gene undergoes
a high to low molecular weight, acidic to basic isoelectric
point splice form switch during development due to alternative
inclusions of N-terminal exons (Jin et al., 2008; Wei et al.,
2014). The alternative splicing of TNNT3 pre-mRNA is regulated
independently of skeletal muscle fiber types as deficiency of slow
skeletal TnT did not affect the developmental switch of fast TnT
splice forms (Wei et al., 2014).
Slow Skeletal Muscle TnT
The slow skeletal muscle TnT gene TNNT1 has a simpler
structure and fewer alternative-splicing variants than that of the
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fast and cardiac TnT genes. There are only 14 exons in the
TNNT1 gene with one alternatively spliced. With exon-intron
organizations same as that of the mammalian slow TnT gene
(Huang and Jin, 1999), chicken slow TnT gene is significantly
smaller (∼3-kb versus ∼11-kb) due to shorter introns (Hirao
et al., 2004). Alternative splicing of exon 5 in the N-terminal
region generates two variants of slow TnT (Gahlmann et al., 1987;
Jin et al., 1998; Huang and Jin, 1999). Splicing at alternative
acceptor sites in intron 5 of mouse slow TnT gene produces
a single amino acid variation in the exon 6-encoded segment
(Huang and Jin, 1999). The same pattern was found for the
splicing of intron 4-exon 5 of chicken slow TnT gene (Hirao et al.,
2004). Abnormal inclusion of 48 bases of the 3′-region of intron
11 was reported in a cloned human slow TnT cDNA (Gahlmann
et al., 1987). However, no corresponding high molecular weight
slow TnT protein was detectable (Jin et al., 1998), implicating a
circumstantial splicing error.
Alternative splicing of slow TnT shows no apparent
developmental regulation but may play a role in modulating
muscle contractility in physiological and pathophysiological
adaptations. While the high molecular weight splice form
including the exon 5-encoded segment is the major slow TnT
expressed in normal muscles, the low molecular weight slow
TnT became predominant in overused prior polio muscle and
significantly up-regulated in type 1 (demyelination), but not
type 2, Charcot-Marie-Tooth disease (Larsson et al., 2008).
Interestingly, the expression of slow skeletal muscle TnT in the
toads hearts as an evolutionarily selected cardiac adaptation to
the drastic changes in blood volume is solely the low molecular
weight splice form (Feng et al., 2012). These observations indicate
differentiated functionalities of the alternative spliced variants of
slow TnT.
Aberrant splicing of slow TnT causes NM (van der Pol et al.,
2014; Abdulhaq et al., 2016). Error splice out of the exon 8-
encoded segment in the middle region of slow TnT drastically
alters themolecular conformation and function in the C-terminal
region and diminishes the binding affinity for tropomyosin
(Amarasinghe et al., 2016).
NEMALINE MYOPATHY MUTATIONS IN
TNNT1 GENE
Multiple mutations in TNNT1 gene, located at 19q13.42 in
the human genome, have been identified to cause autosomal
recessively inherited nemaline myopathies (Table 1 and
Figure 2). The first one was identified in the Old Order
Amish in Lancaster County, Pennsylvania. Known as the
“Chicken Breast Disease” in the Amish community, this
“Amish Nemaline Myopathy” (ANM) is a severe myopathy
disease with infantile lethality (Johnston et al., 2000). ANM
infants exhibit tremors and muscle weakness, followed
by the development of contractures and progressive chest
deformation due to weakness of the respiratory muscles.
Death from respiratory insufficiency usually occurs in the
second year. ANM has an incidence of 1 in ∼500 births
in the Amish communities in Pennsylvania and Ohio
TABLE 1 | TNNT1 myopathies.
Ethnicity Mutation Phenotype References
Old order amish E180ter Recessive NM Johnston et al., 2000; Jin
et al., 2003
Dutch ∆Exon 8 Recessive NM van der Pol et al., 2014
Dutch ∆Exon 14 Recessive NM van der Pol et al., 2014
Hispanic, New York S108ter Recessive NM Marra et al., 2015
Palestinian L203ter Recessive NM Abdulhaq et al., 2016
NM, Nemaline Myopathy.
(Johnston et al., 2000). No effective treatment is currently
available.
The genetic causes of ANM is a nonsense mutation in exon 11
of TNNT1 gene converting the codon Glu180 to a premature stop
codon to truncate the slow TnT polypeptide chain by deleting the
C-terminal 83 amino acids (Johnston et al., 2000). The deletion
of the C-terminal segment of slow skeletal muscle TnT by the
E180ter mutation causes a loss of the binding sites for TnI,
TnC and the tropomyosin-binding site 2 in the T2 region (Jin
et al., 2003; Figure 2). Although, the middle region tropomyosin
binding site 1 remains intact, the truncated slow TnT is not able
to form troponin complex or incorporate into the myofilament
(Wang et al., 2005). This phenotype demonstrates the necessity
of the two-site anchoring of troponin on the thin filament in the
assembly and function of the thin filament regulatory system (Jin
and Chong, 2010).
The truncated ANM slow TnT fragment is not detectable
in the patient muscle (Jin et al., 2003), indicating a rapid
degradation of non-myofilament associated TnT protein and
fragments in muscle cells (Wang et al., 2005). This effective
removal of mutant or damaged TnT from the myocytes when
they are not integrated in the myofibrils is an important
protective mechanism to avoid cytotoxic effect (Jeong et al.,
2009). This mechanism also explains how the various TNNT1
mutations reported to date all present as recessively inherited
diseases (Johnston et al., 2000; van der Pol et al., 2014; Marra
et al., 2015; Abdulhaq et al., 2016). On the other hand, this
mechanism converts a potentially dominant negative mutation
into a recessive mutation, which calls for more extensive genetic
screening of TnT mutations in the clinical diagnosis of recessive
myopathies.
Based on the structural and functional defect of ANM
slow TnT mutant, the molecular basis of the pathogenesis and
pathophysiology of ANM is the complete loss of slow TnT
protein in slow muscle fibers (Jin et al., 2003; Wang et al., 2005).
The loss of slow TnT causes atrophy and degeneration of slow
twitchmuscle fibers that are essential for many vital physiological
activities (Jin et al., 2003). In a transgenic mouse models of ANM,
slow TnT deficiency caused significant decreases in the contents
of type I slow fibers in diaphragm and soleus muscles (Feng et al.,
2009; Wei et al., 2014). Although, the slow TnT deficient slow
fibers had active regeneration and hypertrophic growth of type
II fast fibers, the muscles showed significantly decreased fatigue
resistance (Feng et al., 2009; Wei et al., 2014), consistent with
the pathophysiological phenotype of posture muscle weakness
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FIGURE 2 | Myopathic mutations of TNNT1. Locations of the nonsense and splicing mutations found in TNNT1 gene that truncate the slow TnT polypeptide chain
or causes an internal deletion are illustrated on a linear map of slow TnT protein with the segment encoded by exons 2-14 outlined. The filled box indicates alternatively
spliced exon 5. All of the five TNNT1 mutations cause recessively inherited nemaline myopathies. The known binding sites for TnI, TnC and tropomyosin are outlined.
and respiratory muscle failure in ANM patients (Johnston et al.,
2000).
The identification of ANM and subsequent mechanistic
studies have promoted clinical awareness of TNNT1 myopathy
and its testing in the clinical diagnosis of myopathies. As
results, several recent reports have identified four more TNNT1
mutations in non-Amish ethnic groups, which cause nemaline
myopathies clinically similar to ANM (Table 1). TNNT1
myopathies are, therefore, no longer considered as an isolated
disease of the Amish, but are of increasing medical importance.
The increasing application of genetic screening is anticipated to
identify more TNNT1myopathy mutations.
A nonsense mutation in the exon 9 of TNNT1 gene at codon
Ser108 was found in a Hispanic patient in New York City with
clinical and histological features were very much like that of
ANM, including severe respiratory muscle weakness, type I fiber
atrophy and compensatory hypertrophy of type II fibers (Marra
et al., 2015). The TNNT1 S108ter mutation is predicted to result
in a truncated slow TnT protein missing the C-terminal 155
amino acids. Therefore, the similar recessive phenotypes of the
ANM E180ter and S108ter mutations are based on their loss
of the T2 region TnI and TnC binding sites as well as the
tropomyosin-binding site 2 (Figures 1, 2; Jin and Chong, 2010).
Recent biochemical characterization further demonstrated that
the Ser108 truncation of slow TnT also partially damages the
middle region tropomyosin binding site 1 (Amarasinghe et al.,
2016), which makes it more unlikely to incorporate into the
myofibrils.
A genomic DNA rearrangement in TNNT1 gene (c.574_577
delins TAGTGCTGT) was reported in 9 Palestinian patients from
7 unrelated families with recessively inherited NM (Abdulhaq
et al., 2016). This mutation leads to aberrant splicing to
truncate the slow TnT polypeptide at Leu203 (Figures 1, 2). The
patients presented with recessive NM phenotypes very similar
to that of ANM (Abdulhaq et al., 2016). Biochemical studies
demonstrated that although slow TnT truncated at Leu203 retains
both tropomyosin-binding sites 1 and 2, the inability of forming
troponin complex due to the loss of TnI and TnC binding sites
decreased the binding affinity for tropomyosin, especially at high
calcium (Amarasinghe et al., 2016). This loss of function and
the loss of the highly conserved C-terminal segment may be
responsible for the recessive myopathy phenotype of the Leu203
truncation.
Another case report of a Dutch patient of inherited nemaline
myopathy described two new TNNT1 NM mutations (van der
Pol et al., 2014). The patient also presented with phenotypes
of severe slow skeletal muscle atrophy and weakness similar to
that of ANM. Molecular diagnosis identified that the patient
is a compound heterozygote of a mutation in intron 8 of the
TNNT1 gene that causes aberrant exclusion of exon 8-encoded
sequence and another mutation that causes exclusion of the
exon 14-encoded segment (Figure 2) (van der Pol et al., 2014).
The deletion of exon 8 segment partially destroys the T1 region
tropomyosin-binding site 1 (Figure 1) but preserves the high-
affinity binding site 2 (Jin and Chong, 2010), whereas deletion of
the exon 14-encoded C-terminal end segment would not directly
affect either of the tropomyosin-binding sites, nor the binding
sites for TnI and TnC.
A recent study found that slow TnT with the internal deletion
of the exon 8-encoded segment has drastically decreased binding
affinity for tropomyosin, which is much lower than that of
tropomyosin binding site 2 alone. Deletion of the N-terminal
variable region partially restored the binding affinity of exon 8-
deleted slow TnT (Amarasinghe et al., 2016). These observations
indicate that deletion of the exon 8-encoded segment not only
directly damages the middle region tropomyosin-binding site
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1 but also augments the effect of the N-terminal region on
reducing the binding affinity of site 2. Therefore, the N-terminal
variable region provides a potential target for the treatment of the
myopathy caused by slow TnT exon 8 deletion.
The molecular mechanism for slow TnT exon 14 truncation
to cause recessive myopathy remains to be investigated.
As described in Section Structure-Function Relationship of
Troponin T, there are evidence that the C-terminal end
segment of TnT may contribute to the inhibitory regulation of
myofilament ATPase (Morimoto et al., 1999; Mukherjea et al.,
1999; Franklin et al., 2012). More investigation along this line
would help to understand the pathogenic mechanism of this
aberrant splicing mutation of TNNT1 gene.
PERSPECTIVES: WHAT HAVE BEEN
LEARNED FROM THE PATHOGENIC
MUTATIONS OF SLOW SKELETAL
MUSCLE TNT
Through isoform gene regulation, alternative RNA splicing
and posttranslational modifications, structural and functional
variations of TnT modulate striated muscle contractility.
The fact that the loss of only the slow isoform of TnT
causes lethal myopathy regardless of the mixed composition
and expression of slow and fast TnTs in human skeletal
muscles demonstrates the functional divergence and necessity
of the fiber type-specific TnT isoforms. The critical role
of slow skeletal muscle fibers and the structural-function
relationship of slow muscle TnT demonstrated by the lethal
myopathic mutations and mechanistic studies summarized in
this review provide many novel insights into the structure-
function relationship of TnT and troponin regulation of striated
muscle contraction.
An intriguing feature of the 5 myopathic TNNT1
mutations reported to date is that they all presented as
recessively inherited diseases (Johnston et al., 2000; van
der Pol et al., 2014; Marra et al., 2015; Abdulhaq et al.,
2016). To fully understand the molecular basis of these
different structural defects of slow TnT for causing complete
loss of function from inability of incorporating into the
myofilament will help to further understand the structure-
function relationship of TnT and troponin regulation of muscle
contraction.
Genetically modified mice with a knockdown of the
expression of slow TnT exhibited decreased muscle resistance
to fatigue (Feng et al., 2009). However, carriers of ANM (and
other TNNT1 NM) did not report notable clinical symptom
(Johnston et al., 1997). Therefore, it would be worth further
investigating whether the haploid insufficiency in carriers of
these recessive TNNT1 myopathies may cause conditional slow
TnT deficiency with symptoms such as experiencing conditional
fatigue intolerance and other slow muscle-related dysfunctions.
The potential cytotoxicity of non-myofilament associated slow
TnT fragments (Jeong et al., 2009) in the muscle cells of both
homozygote patients and heterozygote carriers is also worth
investigating. Exhaustive work load or muscle wasting conditions
may produce peaks of myofilament decay to add to the existing
pool of the mutant slow TnT fragment, which may overwhelm
the capacity of protein turnover system in muscle cells to cause
apoptosis and inflammatory damage, although such dominant
negative phenotype might only be a transient state in the muscle
of carriers.
The transient expression of cardiac TnT and embryonic
splice forms of fast skeletal muscle TnT in embryonic and
neonatal skeletal muscle may explain the postnatal onset of
ANM (Jin et al., 2003). This observation suggests a potential
compensation of the fetal forms of TnT for the loss of
slow TnT in ANM neonatal skeletal muscles, which may be
explored as a therapeutic target. This approach would require
an activation of cardiac TnT expression or embryonic alternative
splicing pathways of fast TnT in adult slow skeletal muscle
fibers.
Soleus muscle of slow TnT knockout mouse maintains
a slow fiber cellular environment and exhibits signs of
active regeneration (Wei et al., 2014). This is a plausible
observation suggesting that a restoration of slow TnT in
slow muscle fibers of TNNT1 myopathy patients should
be able to readily rescue muscle growth and functions.
The maintained slow fiber cellular environment and active
regeneration also indicate that translational read-through of
the nonsense stop codon in the muscles of ANM and
S108ter patients may effectively restore muscle function and
growth.
Since TNNT1 myopathies is no longer considered as a
isolated disease of the Amish, and the power of genetic
testing is anticipated to identify more myopathic mutations
of the gene, researchers are urged to add joint effort in TnT
gene expression and structural-function relationship studies,
including the utilization of genetically modified mouse models of
the human diseases, toward the development of effective targeted
treatment of these lethal muscle diseases.
In conclusion, TNNT1 myopathies demonstrate an excellent
example for what we can learn from pathogenic mutations of
a myofilament protein as well as how knowledges learned from
protein structure-function relationship research can help us to
understand the pathogenesis and pathophysiology of genetic
diseases. Therefore, we hope this focused review will benefit
readers with the vision beyond TNNT1myopathy studies.
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